CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Ensuring Access to Critical Medicines for Children
Reinforcing Readiness: Collaborating to End Drug Shortages
CHA Submits Letter on Prioritizing Pediatric Medical Research in FY26 Appropriations
Ensuring Access to Critical Medicines for Children
Discover how Angels for Change partners with manufacturers to prevent shortages and keep lifesaving pediatric drugs available.
Aug. 26, 2025
Reinforcing Readiness: Collaborating to End Drug Shortages
Learn why the Children’s Hospital Association partners with a nonprofit to ensure medications are always available to patients who depend on them.
Aug. 12, 2025
CHA Submits Letter on Prioritizing Pediatric Medical Research in FY26 Appropriations
In collaboration with other pediatrics-focused organizations, CHA submitted a letter highlighting FY26 appropriations requests related to federal funding for pediatric medical research.
July 31, 2025
